Status:
COMPLETED
A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Lead Sponsor:
Ipsen
Conditions:
Neuroendocrine Tumors
Carcinoid Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from ...
Eligibility Criteria
Inclusion
- Out-patients 18 years of age and older, who have agreed to participate in the study
- Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline Autogel
Exclusion
- Subjects for whom there are reasons that may hinder the conduct of the study (patients who have difficulty expressing themselves or who are unable to complete the questionnaires, or with insufficient data in the their files will not be enrolled in the study).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT01234168
Start Date
October 1 2010
End Date
December 1 2012
Last Update
November 5 2020
Active Locations (57)
Enter a location and click search to find clinical trials sorted by distance.
1
Teaching Hospital Brno Bohunice
Brno, Czechia
2
University Hospital Hradec Kralove
Hradec Králové, Czechia
3
Hospital Pardubice
Pardubice, Czechia
4
Teaching Hospital
Pilsen, Czechia